The Obama administrations new top antitrust official in the Federal Trade Commission has an extensive healthcare background and says the commission will continue to focus much of its attention and resources on the industry.
New antitrust chief
Feinstein has healthcare background
Richard Feinstein, a partner in the law firm Boies, Schiller & Flexner, was named director of the FTCs Bureau of Competition last week by Jon Leibowitz, a commissioner since 2004 who was elevated to chairman by President Barack Obama in March. Feinstein, 56, led the FTCs healthcare antitrust enforcement at the end of the Clinton administration, from 1998 to 2001, as an assistant director in the bureau.
Healthcare is going to continue to be at or near the top of their list of priorities, but thats not really new, he said, adding he expects the commission to build on its work over the past several years in hospital mergers and to continue its aggressive interest in patent settlements between pharmaceutical companies.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.